|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A macrophage marker, Siglec-1, is increased on circulating mono- cytes in patients with systemic sclerosis and induced by type I interferous and toll-like receptor agonists 显示文摘 | York MR Nagai T Mangini A J | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 2 | Poly (I:C) drives ype I IFN-and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis显示文摘 | Farina GA York MR Di Marzio M | 2010 | Journal of Investigative Dermatology2010，130，11： | 1 |
| 3 | cAMP activates MAP kinsse and ELK-1 through a B-Raf-and Rapl-dependent pathway显示文摘 | Voasler MR Yao H York RD | 1997 | Cell1997，89，1： | 1 |
| 4 | cAMP activates MAP kinase and Elk-1 through a B-Raf-and Rap 1-dependent pathway显示文摘 | Vossler MR Yao H York RD | 1997 | Cell1997，89，1： | 1 |
| 5 | Comprehensive character- ization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride - induced model of hepatic fibrosis in the temale Hanover Wistar rat 显示文摘 | Smyth R Munday MR York M J | 2007 | lnt J Exp Pathol2007，88，5： | 1 |
| 6 | Poly(I:C) Drives Type I IFN - and TGFβ - Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis 显示文摘 | Farina GA York MR Di Marzio M | 2010 | J Invest Dermatol2010，130，11： | 1 |
| 7 | Teaching evidencebased medicine to internal medicine residents: the efficacy of conferences versus small-group discussion 显示文摘 | Thomas KG Thomas MR York EB | 2005 | Teach Learn Med2005，17，2： | 1 |
| 8 | A distinct lineage of influenza A virus from bats 显示文摘 | Tong S Li Y Rivailler P Conrardy C Castillo DA Chen LM Recuenco S Ellison JA Davis CT York IA Turmelle AS Moran D Rogers S Shi M Tao Y Weil MR Tang K Rowe LA Sammons S Xu X France M Lindblade KA Cox NJ Anderson LJ Rupprecht CE Donis RO | 2012 | Proc Natl Acad Sci USA2012，109，11： | 1 |
| 9 | A macrophage marker,Siglec-1,is increased on circulating monocytes in patients with systemic sclerosis and induced by type Ⅰ interferons and toll-like receptor agonists显示文摘 | York MR Nagai T Mangini AJ | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 10 | A macrophage marker, Siglec-1 ,is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists 显示文摘 | York MR Nagai T Mangini AJ | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 11 | A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I in- terferons and toll-like receptor agonists显示文摘 | York MR Nagai T Mangini A J | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 12 | A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type 1 interferons and toll-like receptor agonists显示文摘 | York MR Nagai T Mangini M | 2007 | Arthritis Rheum2007，56，5： | 1 |
| 13 | A macrophage marker,Siglee-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists 显示文摘 | York MR Nagai T Mangini AJ | 2007 | Arthritis Rheum2007，56，5： | 1 |
| 14 | A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type Ⅰ interferons and toll-like receptor agonists显示文摘 | York MR Nagai T Mangini AJ | 2007 | Arthritis Rheum2007，56，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员